Roche remains the most sustainable healthcare company in the Dow Jones Sustainability Indices

By Catherine Sturman
For the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability I...

For the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI).

The largest biotech company in the world, 30 medicines developed by the company are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.

Based on an in-depth analysis of economic, social and environmental performance, the company serves as a benchmark for investors who integrate sustainability considerations into their portfolios.

 “Our most important contribution to society is the development of medicines and diagnostics that significantly improve people's lives. Open and constructive dialogue with other companies, universities, doctors and patients plays an essential role here in understanding the needs of our partners in the healthcare sector and enabling us to work together to develop more targeted medical solutions faster,” said Roche CEO Severin Schwan.

See also

One example is Roche’s partnership with the Michael J. Fox Foundation for Parkinson's Research (MJFF). Since 2010, Roche has been actively supporting the Parkinson's Progression Marker Initiative (PPMI) as part of a collaboration between companies, non-profit organisations and private individuals.

Through this partnership, Roche will soon start to offer study participants access to its digital biomarker platform, which monitors symptoms of disease progression. The anonymised data collected by the technology will be published by the PPMI publicly on a regular basis, for the whole research community – including Roche’s competitors - to access.

The hope is that this will enable the business to better investigate disease progression, speed up clinical development and improve the treatment of Parkinson's disease by accelerating clinical studies and get urgently needed treatments to patients faster.

Roche follows a holistic approach when managing sustainability: In addition to improving access to products, the company’s strategy also focuses on achieving continuous progress in areas such as social responsibility, environmental protection, supply chain sustainability, people attraction and retention.

Share

Featured Articles

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

LillyDirect’s partnership with Amazon Pharmacy will offer home delivery for diabetes, migraine and obesity medications, including weight-loss drug Zepbound

Schneider Electric: Data Centres ‘are Empowering Healthcare’

Schneider Electric Europe Category Management Director Elliott Turek says data centres are playing a 'pivotal role' in advancing precision medicine

Google Cloud AI Healthcare Solution 'Will Ease Admin Burden'

Google Cloud Vertex AI Search for Healthcare already making a difference for healthcare organisations says Healthcare Strategy Director Aashima Gupta

ADHD Drugs Linked With Lower Risk of Unnatural Death

Medical Devices & Pharma

UnitedHealth Group Cyberattack Sees US Government Respond

Technology & AI

Vaccines Focus Sees GSK CEO Walmsley Land 51% pay Rise

Medical Devices & Pharma